Porphobilinogen oxygenase induction by 2-allyl-2-isopropylacetamide treatment.
D000624:5-Aminolevulinate Synthetase / Q000652:urine; D000081:Acetamides / Q000494:pharmacology*; D000502:Allylisopropylacetamide / Q000494:pharmacology*; D000622:Aminolevulinic Acid / Q000652:urine; D000818:Animals; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D008862:Microsomes, Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000096:biosynthesis*; D010088:Oxidoreductases / Q000096:biosynthesis*; D011162:Porphobilinogen / Q000652:urine; D051381:Rats
D000081:Acetamides; D000502:Allylisopropylacetamide; D011162:Porphobilinogen; D000622:Aminolevulinic Acid; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; C022429:porphobilinogen oxygenase; D000624:5-Aminolevulinate Synthetase